Jerome Stevens Pharmaceuticals, Inc. RX
FDA Approved Drugs

Jerome Stevens Pharmaceuticals, Inc. RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 16
  • Latest Approval Date Nov 30, 2020
  • Data Source FDA
  • First Approval Date Aug 31, 1998
All
33
View
Discontinued
17
View
RX
16
View
Company Overview

Company

Jerome Stevens Pharmaceuticals, Inc. RX

Country

U.S.A

Website

Visit Website

Email

INQUIRIES@JEROMESTEVENS.COM

Social Profiles

Company Snapshot

Jerome Stevens Pharmaceuticals, Inc. RX

JEROME STEVENS PHARMACEUTICALS, INC. 60 DAVINCI DR. BOHEMIA, NY 11716

U.S.A

www.unithroid.com/ INQUIRIES@JEROMESTEVENS.COM View on Map
FDA Approved Drug Records ( 16 records )
1998
31 Aug
RX Application: 74951

Drug Name

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

1998-08-31

74951 / 1

Active Ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Application Number

74951

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

1998-08-31

Regulatory Status

RX

2002
26 Jul
RX Application: 76268

Drug Name

DIGOXIN

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2002-07-26

76268 / 1

Active Ingredient

DIGOXIN

Application Number

76268

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2002-07-26

Regulatory Status

RX

2002
26 Jul
RX Application: 76268

Drug Name

DIGOXIN

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2002-07-26

76268 / 2

Active Ingredient

DIGOXIN

Application Number

76268

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2002-07-26

Regulatory Status

RX

2020
30 Nov
RX Application: 214047

Drug Name

THYQUIDITY

Product Number

1

Dosage Form

-

Strength

100MCG/5ML

Approval Date

2020-11-30

214047 / 1

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

214047

Product Number

1

Dosage Form

-

Strength

100MCG/5ML

Approval Date

2020-11-30

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

1

Dosage Form

-

Strength

0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 1

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

1

Dosage Form

-

Strength

0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

2

Dosage Form

-

Strength

0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 2

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

2

Dosage Form

-

Strength

0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

3

Dosage Form

-

Strength

0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 3

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

3

Dosage Form

-

Strength

0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

4

Dosage Form

-

Strength

0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 4

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

4

Dosage Form

-

Strength

0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

5

Dosage Form

-

Strength

0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 5

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

5

Dosage Form

-

Strength

0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

6

Dosage Form

-

Strength

0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 6

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

6

Dosage Form

-

Strength

0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

7

Dosage Form

-

Strength

0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 7

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

7

Dosage Form

-

Strength

0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

8

Dosage Form

-

Strength

0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 8

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

8

Dosage Form

-

Strength

0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

9

Dosage Form

-

Strength

0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 9

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

9

Dosage Form

-

Strength

0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

10

Dosage Form

-

Strength

0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 10

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

10

Dosage Form

-

Strength

0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2000
21 Aug
RX Application: 21210

Drug Name

UNITHROID

Product Number

11

Dosage Form

-

Strength

0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

21210 / 11

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

11

Dosage Form

-

Strength

0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2000-08-21

Regulatory Status

RX

2008
08 Feb
RX Application: 21210

Drug Name

UNITHROID

Product Number

12

Dosage Form

-

Strength

0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2008-02-08

21210 / 12

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21210

Product Number

12

Dosage Form

-

Strength

0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2008-02-08

Regulatory Status

RX

Related Databases
  • FDA Inspections
    14 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    33 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
16 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

Application Number

74951

Product Number

1

Active Ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit